Browsing Tag
NRTX-1001
3 posts
What rezanecel’s durability data means for epilepsy treatment innovation
Neurona Therapeutics’ rezanecel shows durable seizure reduction. Discover what this means for epilepsy treatment innovation and future market dynamics.
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
UCB is acquiring Neurona for up to $1.15 billion to deepen its epilepsy pipeline. Read what the deal means for growth, risk, and biotech competition.
Schroders Capital invests in Neurona Therapeutics to advance neural cell therapies
In a significant development for the life sciences sector, Schroders Capital Global Innovation Trust plc has announced a…